About
Hassan Mirzaei is a researcher in Pharmacy at Golestan University of Medical Sciences. Based in Iran. Research interests include Pharmaceutical Chemistry, Drug Delivery.
Research keywords
Publications
25Comparison of Hibiscus sabdariffa L. extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
Objective: L. extract (HSE) as a supplemental therapy with valsartan for type 2 diabetic patients with nephropathy and its underlying biological functions were investigated in this study. Materials and Methods: This clinical trial took place in Gorgan, Iran with 70 diabetic nephropathy patients who had hypertension. The participants were divided into two groups: The HSE group which received 500 mg HSE along with valsartan 40 mg twice daily over three months (n=35) and the control group which received valsartan plus hydrochlorothiazide 12.5 mg (n=35). The study measured blood pressure levels with additional assessments of microalbuminuria, proteinuria, and glomerular filtration rate (GFR) alongside lipid profile analysis, and hemoglobin A1c (HbA1c), fasting blood glucose (FBS), and electrolyte tests. Molecular docking simulations tested HSE compounds as potential inhibitors of sodium-glucose cotransporter-2 (SGLT2), dipeptidyl peptidase-4 (DPP-4), glucagon-like peptide-1 (GLP-1), and Receptor for advanced glycation end products (RAGE). Results: Both groups showed improvements, but HSE had a greater impact on kidney function and lipid levels, while control group was more effective in lowering blood pressure and improving glucose metabolism. Docking analysis revealed that cyanidin 3-O-beta-D-sambubioside and tiliroside strongly interacted with targets, suggesting a role in blood glucose regulation and insulin secretion. Conclusion: HSE demonstrates the potential to help type 2 diabetic nephropathy patients by modifying renin-angiotensin-aldosterone system activity carbohydrate digestion processes and lipid metabolism which reduces diabetic complications risks.
In Vitro, In Silico, and Scanning Electron Microscopy Study of Anti-leishmanial Efficacy of New Synthetic 3-Imidazolyl Flavan Fxime on Leishmania tropica
INTRODUCTION: Antimonials have been traditional therapeutic agents for leishmaniasis for decades, but selecting the optimal treatment regimen remains challenging. Alternative systemic treatments, including liposomal amphotericin B and sodium stibogluconate, have shown unclear efficacy in Leishmania tropica cutaneous leishmaniasis. The objective of this study was to evaluate the efficacy of a new synthetic 3-Imidazolyl flavan oxime (IFO) against Leishmania tropica, using in vitro, in silico, and Scanning Electron Microscopy (SEM) analyses. METHODS: A standard strain of Leishmania tropica was cultured to assess the in vitro antileishmanial effects of the new synthetic azole. Additionally, scanning electron microscopy was conducted to reveal structural changes in the parasite during treatment. RESULTS: The IC50 value of IFO was 26.5 µg/mL for the promastigote stage, which was significantly lower than that of ketoconazole (KCZ, IC50 = 192 µg/mL) and meglumine antimoniate (MA, IC50 = 234 µg/mL) (P < 0.05). IFO also decreased the Mean Infection Rate (MIR) to 24.78 ± 9.66% and the Mean Number of Amastigotes Per Macrophage (MNAPM) to 1.69 ± 0.31. These values for macrophages treated with KCZ were 37.78 ± 9.18 and 1.91 ± 0.43, with MA 53.33 ± 17.79% and 2.04 ± 0.36, and control 76.67 ± 1.53 and 3.17 ± 0.14, respectively (P = 0.01). Parasite survival (PS) for IFO, KCZ, MA, and control was 53.31 ± 0.26%, 60.25 ± 1.73%, 64.35 ± 1.64%, and 76.67 ± 1.53%, respectively. Inhibition of intracellular amastigote growth (%) for IFO, KCZ, and MA was 46.7%, 35.65%, and 20.38%, respectively. DISCUSSION: Cutaneous leishmaniasis is a significant health problem that has faced treatment challenges, motivating the search for new therapeutic compounds. Azoles have demonstrated considerable anti-leishmanial effects and have attracted attention as potential treatment options. Our synthetic azole exhibited reliable efficacy against L. tropica in both amastigote and promastigote stages, with low toxicity. CONCLUSION: The results demonstrated notable anti-leishmanial effects of IFO against Leishmania tropica, suggesting it may be considered a potent therapeutic agent.
Nutraceuticals Targeting Cannabinoid Receptor 1 and Transient Receptor Potential Vanilloid 1 for Pain Relief: A Computational Screening Approach
OBJECTIVE: This study examined the binding affinities and therapeutic potential of natural products targeting pain-related receptors using molecular docking and molecular dynamics (MD) simulations. Drug-like properties and absorption, distribution, metabolism, excretion, and toxicity (ADMET) analyses were also conducted. METHODS: AutoDock Vina (The Scripps Research Institute, La Jolla, CA, USA) was used for docking against pain-related receptors, including transient receptor potential vanilloid 1 (TRPV1), cyclooxygenase-2 (COX-2), cannabinoid receptor 1 (CB1), mu-opioid receptor, and nicotinic acetylcholine receptors. Celecoxib was included as a reference drug for docking score comparison. Protein-ligand complex stability was assessed via 100-nanosecond (ns) MD simulations using GROMACS (GROningen MAchine for Chemical Simulations; the University of Groningen, Netherlands), analyzing root mean square deviation (RMSD) and radius of gyration (Rg). Drug-likeness was evaluated by Lipinski's rule of five, and ADMET analysis was performed for pharmacokinetics and toxicity profiling. RESULTS: Ginsenoside Rb1 exhibited a strong affinity for TRPV1 (-9.5 kcal/mol) and mu-opioid (-9.0 kcal/mol) receptors, suggesting its potential as a non-opioid analgesic candidate. Cyanidin 3-O-rutinoside demonstrated high binding to TRPV1 (-9.35 kcal/mol), COX-2 (-9.65 kcal/mol), and CB1 (-9.18 kcal/mol), surpassing the reference drug celecoxib (-7.22 kcal/mol) in COX-2 binding. MD simulations confirmed complex stability, with RMSD (~3.0 Å) and Rg (~3.0 nm) values lower than unbound proteins. Most compounds met Lipinski's criteria, indicating good oral bioavailability. ADMET analysis revealed favorable absorption and distribution with low toxicity. CONCLUSION: Ginsenoside Rb1 and cyanidin 3-O-rutinoside exhibit high binding affinity, stability, and favorable pharmacokinetic properties, supporting their potential as non-opioid analgesic candidates. Their ability to modulate pain pathways in vitro and in vivo warrants further investigation.
Impact of Preoperative Nutritional Status on Postoperative Outcomes in Laparoscopic Cholecystectomy: A Study From Basra Teaching Hospital
Background Malnutrition is associated with adverse events, and nutritional status is a significant determinant of surgical outcomes. Its precise effect on typical postoperative outcomes after laparoscopic cholecystectomy (LC), a common short-stay procedure carried out in a population that is generally healthy, is still up for debate. Objective The primary objective of this investigation was to assess the relationship between the incidence of postoperative pain, postoperative nausea and vomiting (PONV), and length of hospital stay (LOS) and preoperative nutritional status as determined by the Mini Nutritional Assessment-Short Form (MNA-SF). Investigating the connections between serum albumin, body mass index (BMI), and the primary outcomes of nutritional status and kidney function was the secondary goal. Methods A total of 140 patients, aged 30 to 60 years, who had elective LC at Basra Teaching Hospital were included in this prospective observational study. Demographic information, laboratory markers like serum albumin, and nutritional assessments using the MNA-SF and BMI were all part of the preoperative evaluations. LOS, PONV incidence, and pain (Visual Analogue Scale) were among the postoperative outcomes that were prospectively documented over 24 hours. To evaluate correlations and associations, statistical analyses were conducted. Results The mean age of the 140 patients was 40.7±8.98 years, and 125 (89.3%) were female. The MNA-SF found that 26 patients (18.6%) were malnourished and 72 patients (51.4%) were at risk of malnutrition. There was no significant correlation found between the MNA-SF score and LOS (p=0.984), PONV (p=0.317), or postoperative pain (p=0.468). On the other hand, a lower incidence of PONV was substantially linked to a higher BMI (p=0.049). There was a significant correlation between lower postoperative systolic (p=0.005) and diastolic (p=0.039) blood pressure and lower preoperative serum albumin levels. Conclusion Although the MNA-SF's overall nutritional screening seems to have little predictive ability for common complications in this non-elderly LC cohort, certain indicators, such as serum albumin and BMI, may be able to help identify patients who are at risk for particular adverse events. These indicators may help guide focused perioperative strategies, as evidenced by the correlations found between lower albumin and a propensity for postoperative hypotension and between higher BMI and lower PONV.
Roselle (Hibiscus sabdariffa L.) extract as an adjunct to valsartan in patients with mild chronic kidney disease: A double-blind randomized controlled clinical trial.
Objective: L. extract (HS) as an adjunct to valsartan in the treatment of high blood pressure in patients with mild chronic kidney disease (CKD). Materials and Methods: This trial was conducted in Gorgan, Iran. Seventy-two participants with CKD and high blood pressure were randomly assigned to either the HS group, receiving a 350 mg pill every 12 hr for 90 days along with 40 mg of valsartan every 12 hr, or the control group (40 mg valsartan + 12.5 mg hydrochlorothiazide). The primary objective was to assess the improvement of hypertension, while secondary objectives included the evaluation of proteinuria, albuminuria, kidney function, lipid profile, and electrolyte levels. Molecular docking analysis was performed to examine the mechanisms of action of the isolated components of HS. Results: Out of 80 initial participants, 72 were included in the analysis. Both groups showed a significant reduction in blood pressure (p<0.001). The HS group demonstrated a statistically significant decrease in lipid profile (p<0.001). There were no statistically significant differences between the groups regarding the reduction of renal markers. Molecular docking analysis revealed that the compounds present in HS, particularly its anthocyanins and flavonoids, exhibited greater angiotensin-converting enzyme (ACE) inhibitory potential than hydrochlorothiazide in both domains. Moreover, the compounds met the criteria for drug likeness and Lipinski rules. Conclusion: Adjunctive therapy with HS showed promising results in reducing hypertension and improving lipid profile in patients with CKD.
Anti-inflammatory and anticancer activities of boron nitride nanotubes functionalized with curcumin: Density functional theory and molecular docking studies
Potential antiplatelet agents with grape seed – backbone polyphenols: computational studies
The study focused on grape seed-derived polyphenols for their antiplatelet, anti-inflammatory, and fibrinolytic properties through molecular docking and dynamics simulations. Compounds were evaluated for their effects on P2Y12, PTP1B, thromboxane A2, and other targets. Compounds 1 and 6 showed strong inhibitory potential on P2Y12. Compounds 2 and 7, plus epigallocatechin gallate, demonstrated effective inhibition on NF-KB and COX1. The compounds exhibited drug-like properties and potential for new thrombotic disease therapies. The research sheds light on the interactions between polyphenols and target proteins, paving the way for novel antiplatelet strategies.
Repurposing of monacolin K decorated BN nanoparticle on inhibition of HMG-CoA reductase: In silico approach
To identify a novel inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase, the current perspective has shifted toward a B12N12 nanocage that also has cardioprotective properties. Therefore, this study identified the bioactive complexes derived from monacolin K and BN nanoparticle and determines their potential for inhibiting HMG-CoA reductase, hypolipidemic activity, and anti-apoptotic properties via molecular docking. A molecular docking study was conducted with the Auto Dock Vina software on a complex of monacolin K and the B12N12 fullerene using an in silico docking approach. The protein structures of selective HMG-COA reductase, as well as peroxisome proliferator-activated receptor-α (PPAR-α) and others, were obtained from Protein Data Bank (PDB). The binding affinity between key residues involved in the binding mode of the targets and selective complexes is identified via in silico molecular docking. A further evaluation of the ADMET properties of the selective complexes has also been carried out. B12N12 nanoparticles and monacolin K complex (A) showed higher inhibitory potential for HMG-CoA reductase than monacolin K alone. These complexes seemed to be selective to the PPAR-α and caspase3 domains. Meanwhile, complex B had the highest binding affinity to the active site of SGK, TNF- α, NF-Kβ and AMPK receptors. Furthermore, both complex A and B could inhibit inflammatory targets more efficiently. The selective B12N12 nanoparticles were assessed for their drug-likeness and ADMET analysis, confirming that the selective B12N12 nanoparticles met the Lipinski and drug-likeness criteria. It was revealed that B12N12 fullerene and monacolin K complexes have potential inhibitory HMG-COA reductase and anti-apoptotic properties, as well as activating PPAR-α and AMPK. Consequently, these cardioprotective effects lead to improved cardiovascular health.
Density functional theory and molecular docking studies on electronic and optical features of poly (lactic acid) interacting with celecoxib
This study aims to clarify the molecular mechanism by which celecoxib (CXB) interacts with poly (lactic acid), (PLA), microparticles using calculations from density functional theory (DFT), time-dependent density functional theory (TDDFT), and molecular docking. Chemical reactivity and binding energy parameters indicate that the interaction of CXB through the pyrazole ring with PLA (state A: -1.52 eV) is stronger due to hydrogen bonding than in states B (-0.36 eV) and C (-0.44 eV) due to weak hydrogen bonding interactions. The infrared (IR) and Ultraviolet-Visible (UV-Vis) absorption spectra reveal that both pure PLA and CXB experience shifts as a result of the interaction between CXB and PLA. The interaction between CXB (5.07 Debye) and PLA (7.33 Debye) results in an increase in the dipole moment (B: 39.86 Debye), an improvement in solubility, and a reduction in the energy gap (Eg). In comparison to free molecules, the designed models, including CXB and PLA, showed greater stability in the protein's active pocket based on molecular docking calculations. Therefore, CXB interacting with PLA acts as a potent inhibitor of tumor necrosis factor-alpha (TNF-α), cyclooxygenase-2 (COX-2), and human epidermal growth factor receptor-2 (HER2).and can be used to treat breast cancer patients as well as immune-inflammatory diseases like rheumatoid arthritis (RA).
LC–MS/MS phytochemical profiling, antioxidant activity, and enzyme inhibitory of Potentilla reptans L. root: Computational studies and experimental validation
Evaluation of facial anthropometric characteristics in infants born in north of Iran
Potentilla reptans L. preconditioning regulates H19 and MIAT long noncoding RNAs in H9C2 myoblasts Ischemia/Reperfusion model
Abstract The present study aimed to evaluate the effect of the ethyl acetate fraction of P. reptans root (PEF) preconditioning on expressions of lncRNAs H19 and MIAT in H9C2 myoblasts I/R injury. H9C2 cells were treated with different concentrations ranging from (10–400 µg/ml) of PEF for 24 h, followed by simulation of I/R condition. For I/R experiments, H9C2 cells were subjected with the oxygen and glucose deprivation for 2 h. H9C2 cell viability was significantly enhanced by PEF preconditioning under I/R condition in a concentration-dependent manner up to 200 µg/ml as a EC50. The PEF significantly diminished the expression of lncRNA MIAT and rate of apoptosis against the I/R group. In addition, PEF pretreated before stimulation I/R condition increased H19 expression compared to the normal PEF group with no statistically significant differences between groups. Hence, the results suggest that PEF can protect cardiomyocytes during hypoxia-induced myocardial cell injury by targeting specific involved genes.
Chromenone-based GSK-3β inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles
Glycogen synthase kinase-3 beta (GSK-3β) regulates glycogen metabolism and many different cellulars, including apoptosis, signaling, and neural. It is a crucial therapeutic receptor in heart disease, type 2 diabetes, and Alzheimer's. In this study, using computational methods, flavonoid compounds were investigated for potential inhibitors against GSK-3β. Virtual screening was utilized to investigate flavonoid compounds obtained from the PubChem database. Structure of human heart mitochondria of GSK-3β receptor constructed by homology modeling. Best binding poses were discovered via in silico molecular docking simulation. We surveyed noncovalent interactions among amino acid residues involved in the active site of the modeled Protein and compounds via molecular docking and molecular dynamics (MD). Moreover, ADMET characteristics of best docking conformers have been investigated. The obtained results revealed that compound 1 containing chromenone moiety with binding energy H-bond −11.4 kcal/mol inhibited effectively binding pocket of the GSK-3β receptor. Moreover, MD simulation analysis (RMSD and radius of gyration indicated complex of the compound and GSK-3β receptor remained stable throughout 100 ns MD simulation, and also analysis of ADMET profiles revealed that selected compounds had good drug-likeness and pharmacokinetic properties. Hence, it was suggested that compounds with chromenone scaffold could potentially inhibit GSK-3β. Structural modification of the chromenone derivatives may result in the discovery of promising candidates for identifying novel drugs as GSK-3β inhibitors.
Chromenone-based GSK-3ß inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles
Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile
In the novel SARS-CoV-2 (COVID-19) as a global emergency event, the main reason of the cardiac injury from COVID-19 is angiotensin-converting enzyme 2 (ACE2) targeting in SARS-CoV-2 infection. The inhibition of ACE2 induces an increase in the angiotensin II (Ang II) and the angiotensin II receptor type 1 (AT1R) leading to impaired cardiac function or cardiac inflammatory responses. The ethyl acetate fraction of Potentilla reptans L. root can rescue heart dysfunction, oxidative stress, cardiac arrhythmias and apoptosis. Therefore, isolated components of P. reptans evaluated to identify natural anti-SARS-CoV-2 agents via molecular docking. In silico molecular docking study were carried out using the Auto Dock software on the isolated compounds of Potentilla reptans root. The protein targets of selective ACE and others obtained from Protein Data Bank (PDB). The best binding pose between amino acid residues involved in active site of the targets and compounds was discovered via molecular docking. Furthermore, ADMET properties of the compounds were evaluated. The triterpenoids of P. reptans showed more ACE inhibitory potential than catechin in both domains. They were selective on the nACE domain, especially compound 5. Also, the compound 5 & 6 had the highest binding affinity toward active site of nACE, cACE, AT1R, ACE2, and TNF-α receptors. Meanwhile, compound 3 showed more activity to inhibit TXA2. Drug likeness and ADMET analysis showed that the compounds passed the criteria of drug likeness and Lipinski rules. The current study depicted that P. reptans root showed cardioprotective effect in COVID-19 infection and manipulation of angiotensin II-induced side effects.
Electrostatic interaction assisted Ca-decorated C20 fullerene loaded to anti-inflammatory drugs to manage cardiovascular disease risk in rheumatoid arthritis patients
Investigations of adsorption behavior and anti-cancer activity of curcumin on pure and platinum-functionalized B12N12 nanocages
Molecular Modeling and Simulation of glycine functionalized B12N12 and B16N16 nanoclusters as potential inhibitors of proinflammatory cytokines
Penicillamine functionalized B12N12 and B12CaN12 nanocages act as potential inhibitors of proinflammatory cytokines: A combined DFT analysis, ADMET and molecular docking study
The adsorption of penicillamine (PCA) on pure B12N12 and B12CaN12 nanocages in aqueous and chloroform solvents has been evaluated using density functional theory (DFT) calculations. The interaction of PCA on B12N12 nanocages is chemisorption through its four nucleophilic sites: amine, carbonyl, hydroxyl and thiol. The most stable adsorption configuration was achieved when zwitterionic PCA adsorbs via its carbonyl group in water with value of −1.723 eV, in contrast, when neutral PCA adsorbs via its amine group in chloroform with value of −1.68 eV. Intercalated calcium ion within B12N12 nanocage (B12CaN12) was shown to attract PCA onto nanocage surface, resulting in higher solubility and adsorption energy after their complexation in water and chloroform. The adsorption of multiple PCA molecules from their amine and carbonyl groups on pure and B12CaN12 nanocages were also evaluated where two and three molecules can be chemisorbed on boron atoms of the nanocage surfaces with the adsorption energy per PCA reduces slightly with the increasing the amount of drugs due to the curvature effects. Molecular docking study indicates that PCA from its NH2 group on B12CaN12 nanocage has the best binding affinity and inhibition potential of tumor necrosis factor-alpha (TNF-α) and Interleukin-1 (IL-1) receptors as compared with the other adsorption systems. Molecular docking and ADMET analysis displayed that the chosen compounds pass Lipinski Rule and have appropriate pharmacokinetic features suitable as models for developing anti-inflammatory agents.
Predicting adsorption behavior and anti-inflammatory activity of naproxen interacting with pure boron nitride and boron phosphide fullerene-like cages
Molecular Docking Study and ADMET Profile: Manipulation of Angiotensin II Pathophysiology in COVID-19 by Potentilla Reptans Root Compounds
Abstract In the novel SARS-CoV-2 (COVID-19) as a global emergency event, the main reason of the cardiac injury from COVID-19 is angiotensin-converting enzyme 2 (ACE2) targeting in SARS-CoV-2 infection. The inhibition of ACE2 induces an increase in the angiotensin II (Ang II) and the angiotensin II receptor type 1 (AT1R) leading to impaired cardiac function or cardiac inflammatory responses. The ethyl acetate fraction of Potentilla reptans L. root can rescue heart dysfunction, oxidative stress, cardiac arrhythmias and apoptosis. Therefore, isolated components of P. reptans evaluated to identify natural anti-SARS-CoV-2 agents via molecular docking. In silico molecular docking study were carried out using the Auto Dock software on the isolated compounds of Potentilla reptans root. The protein targets of selective ACE and others obtained from Protein Data Bank (PDB). The best binding pose between amino acid residues involved in active site of the targets and compounds was discovered via molecular docking. Furthermore, ADMET properties of the compounds were evaluated. The triterpenoids of P. reptans showed more ACE inhibitory potential than catechin in both domains. They were selective on the nACE domain, especially compound 5. Also, the compound 5 & 6 had the highest binding affinity toward active site of nACE, cACE, AT1R, ACE2, and TNF-α receptors. Meanwhile, compound 3 showed more activity to inhibit TXA2. Drug likeness and ADMET analysis showed that the compounds passed the criteria of drug likeness and Lipinski rules. The current study depicted that P. reptans root showed cardioprotective effect in COVID-19 infection and manipulation of angiotensin II-induced side effects.
Improvement of anti-inflammatory and anticancer activities of poly(lactic-co-glycolic acid)-sulfasalazine microparticle via density functional theory, molecular docking and ADMET analysis
In the present study, we assessed improvement of anti-inflammatory activity and drug delivery of sulfasalazine (SSZ) by the poly(lactic-co-glycolic acid), (PLGA), in H2O and dichloromethane (DCM) environments via density functional theory (DFT), ADMET, and molecular docking. Our calculated results based on binding energy and thermodynamic parameter represents that the interaction between SSZ and PLGA in Complex A via double hydrogen bonds is stronger in comparison with Complex B. The analysis of Ultraviolet–visible (UV–VIS) spectra proved the interaction of SSZ with PLGA by time-dependent density functional theory (TDDFT). Infrared (IR) spectra demonstrated that the structure of PLGA was shifted in the presence of the SSZ. The interaction of SSZ with PLGA leads to an increase in dipole moment and higher solubility with more negative Gibbs free solvation energy (ΔGsolv) values and lowering of the energy gap (Eg). The obtained results by Molecular docking demonstrates that the interaction of SSZ via its carboxylate group with PLGA (complex A) had a strong interaction towards the binding pocket of the target and as a potential inhibitor of the COX-2, TNF-α, and IL-1 receptors at the binding site as compared with the complex B.
Six new triterpenoids from the root of Potentilla reptans and their cardioprotective effects in silico
Tormentic acid ester glucosides derivatives (1, 2 and 4), 3-oxoursane ester glycoside (3) and 11-methoxy-ursane ester glycosides (5, 6) as six new triterpenoids, along with catechin were isolated from the ethyl acetate fraction of Potentilla reptans root (Et) methanolic extract. The structures of the compounds were elucidated by 1D, 2D NMR, IR and MS spectroscopy. Additionally, isolated triterpenoid compounds (1–6) and catechin were evaluated for their cardioprotective effects via glycogen synthase kinase 3β (GSK-3β) and glucocorticoid regulated kinase-1 (SGK1) protein kinase inhibition by Molecular Docking. Compound 1 and catechin (compound 7) exhibited significant inhibitory effects against GSK-3β and SGK1 protein kinases with a binding energy value −9.1 and −8.8 kcal/mol, respectively. Hence, Et can be a suitable natural candidate to protect cardiomyocytes injury.
Data on molecular docking of tautomers and enantiomers of ATTAF-1 and ATTAF-2 selectivty to the human/fungal lanosterol-14α-demethylase
The data have been obtained for tautomers and enantiomers of ATTAF-1 and ATTAF-2 that were developed based on antifungal standard drugs with triazole scaffold. These compounds were docked into the human and fungal lanosterol-14α-demethylase. In order to validate the data, 8 standard triazole antifungal drugs (Fluconazole, Itraconazole, Posaconazole, Ravuconazole, Albaconazole, Voriconazole, Isavuconazole and Efinaconazole) were also docked into the human and fungal lanosterol-14α-demethylase. The binding conformations of these molecules and their interactions with lanosterol-14α-demethylase may inform the development of further small molecule lanosterol-14α-demethylase inhibitors with significant selectivity toward this enzyme. The analysis has done on the basis of type of interactions (bond type and distance). The length of the Fe-N coordination bond for (R)-N2-ATTAF-1 and (S)-N1-ATTAF-2 complexes is obtained 6.36 and 4.19 Å, respectively and about 2 Å in the other tautomer and enantiomer complexes, reflecting the lower basicity of the N-4 atom in the 1,2,4-triazole ring of (R)-N2-ATTAF-1 and (S)-N1-ATTAF-2 in comparison with the N-4 atom in the 1,2,4-triazole ring in other tautomers and enantiomers and supporting higher selectivity of (R)-N2-ATTAF-1 and (S)-N1-ATTAF-2 towards the target CYP51 enzymes vs. human. Interestingly, we have investigated unfavorable interactions (donor-donor) with TRP239 and MET378 for (R)-N2-ATTAF-1 and (S)-N1-ATTAF-2, respectively. These unfavorable interactions also have been seen in case of posaconazole and isavuconazole. The data presented in this article are related to the research paper entitled "In silico prediction of ATTAF-1 and ATTAF-2 selectivity towards human/fungal lanosterol 14α-demethylase using molecular dynamic simulation and docking approaches".